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Edited by David LambethAbstract Previously, we found that safrole oxide could trigger
vascular endothelial cell (VEC) apoptosis. In this study, to inves-
tigate its mechanism to induce apoptosis in VECs, the activities
of nitric oxide synthetase and phosphatidylcholine speciﬁc phos-
pholipase C, the level of reactive oxygen species and the expres-
sions of Fas, integrin b4 and P53 were analyzed. The data
showed that safrole oxide induced apoptosis by increasing the
expressions of Fas, integrin b4 and P53, and depressing the
activity of Ca2+-independent phosphatidylcholine-speciﬁc phos-
pholipase C and intracellular reactive oxygen species levels in
VECs.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
Keywords: Safrole oxide; Apoptosis; Mechanism; Endothelial
cells1. Introduction
Vascular endothelial cells have important roles in vascular
development. Many experiment results show that dysregula-
tion of vascular endothelial cell apoptosis is involved in the
pathophysiology of various inﬂammatory and degenerative
diseases. The regulation of endothelial cell apoptosis was as
a potential therapeutic target to blood vessel diseases [1].
Accordingly, the current review focuses on the utilization of
a new research engine, chemical genetics, to discover novel
VEC apoptosis promoters and their targets, and to validate
their biological relevancy and provide new insights into the
biological role of targets in vascular development [2].
In our previous studies, safrole oxide was synthesized [3,4],
and its eﬀects on growth and apoptosis of VEC were examined.
Safrole oxide 5–25 mg/L inhibits, but 50–100 mg/L promotes
apoptosis of VEC [5]. And 70 mg/L of safrole oxide eﬀectively
inhibited angiogenesis [6]. However, the molecular mechanism
of safrole oxide inducing VEC apoptosis remained undeﬁned.
According to our previous results, we made a research on the
molecular mechanism of VEC apoptosis triggered by safroleAbbreviations: NOS, nitric oxide synthetase; PC-PLC, phosphatidyl-
choline-speciﬁc phospholipase C; ROS, reactive oxygen species;
DCHF, 20,70-dichloroﬂuorescin; VEC, vascular endothelial cell
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proteins, so as to provide new insights into the biological roles
of these targets in VEC apoptosis.2. Materials and methods
2.1. Cell culture
Human umbilical vein endothelial cells were gained as described pre-
viously [7]. Cells were grown in MCDB131 medium (Sigma) supple-
mented with 10% (v/v) fetal calf serum and 80 mg/L FGF [8]. All
experiments were performed on cells from 10 to 20 passages.
2.2. Exposure of VEC to safrole oxide
When the cultures of VEC reached sub-conﬂuence, the culture medium
was replaced with basal MCDB131 culture medium (without FGF and
FBS) after once wash with the same medium. Then the cells were treated
in twoways. (a)As a control group, cells were cultured in basalMCDB131
medium. (b) Cells were incubated with safrole oxide 70 mg/L for 10 h.
2.3. Immunoﬂuorescence
Immunoﬂuorescence was performed as the method of Zhao et al. [9].
After adding the primary (Mouse anti-human P53, Integrin b4, Fas)
and second antibodies (FITC-IgG) (Santa Cruz Biotechnology), sam-
ples were evaluated with laser scanning confocal microscopy (Leica,
Germany). The immunoﬂuorescence techniques allow semiquantitative
evaluation of protein expression [10].
2.4. Western blot analysis
Western blot assay was performed by the same method as previously
described [11]. The relative quantity of proteins was analyzed by
Imagetool software.
2.5. NOS activity assay
The enzymes were prepared as described by Wu et al. [12]. The levels
of nitric oxide in cells were assessed according to the instructions pro-
vided by NOS detection kit (Nanjing Jiancheng). The optical density
was measured at 530 nm (wavelength). The enzyme activity was ex-
pressed as U per mg of protein (U/mg prot).
2.6. PC-PLC activity assay
PC-PLC activity assay was done as the method of Wu et al. [12]. In
brief, we prepared the enzyme and used L-a-phosphatidylcholine (Sig-
ma) as the substrate of phosphatidylcholine-speciﬁc phospholipase C
(PC-PLC). The optical density was measured at 660 nm (wavelength).
The enzyme activity was expressed as nmol per min per mg of protein
(nmol/min mg).
2.7. ROS assay
A ﬂuorescent probe, 2 0,7 0-dichloroﬂuorescin (DCHF) (Sigma),
which could be oxidized into DCF by the intracellular reactive oxygen
species (ROS) while entering into cells, was used for the assessment of
intracellular ROS formation in cultured VECs. ROS assay was done asation of European Biochemical Societies.
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tiﬁed by the software of Zeiss LSM510 and the photographs were rep-
resentatives in the scan rooms.
2.8. Statistical analysis
The results are expressed as the means ± S.E. Statistical analysis was
done by t test, and diﬀerences at P < 0.05 were considered statistically
signiﬁcant.3. Results
3.1. Eﬀect of safrole oxide on the expression of Fas
The results of Western blot analysis revealed an about 2-fold
increase in Fas expression in cells treated by safrole oxide
70 mg/L (Fig. 1A). The results of indirect immunoﬂuorescence
experiments were consistent with that of Western blot analysis
(Fig. 1B). The results showed that safrole oxide could upregu-
late the expression of Fas, indicating that it might trigger VEC
apoptosis by promoting the apoptosis signal pathway medi-
ated by Fas.
3.2. Eﬀect of safrole oxide on the activity of NOS
As shown in Fig. 2, the results showed that safrole oxide had
no eﬀects on nitric oxide synthetase (NOS) activity, suggesting
that NOS was not involved in safrole oxide triggered VEC
apoptosis.
3.3. Eﬀect of safrole oxide on the activity of PC-PLC
The activity of PC-PLC, including Ca2+-dependent PC-PLC
and Ca2+-independent PC-PLC, was evaluated following theFig. 1. Eﬀect of safrole oxide on the expression of Fas. A: (A) The bands o
depicted as a bar chart. **, P < 0.01 vs #, n = 3. B: (A) Fluorescent micrograp
cultured in the basal medium; (b) cells treated with safrole oxide 70 mg/L. (B
relative ﬂuorescent intensity per cell determined by laser scanning confocal mtreatment with safrole oxide. As a result, Ca2+-dependent
PC-PLC was nearly not changed. But 70 mg/L of safrole oxide
suppressed the activity of Ca2+-independent PC-PLC obvi-
ously (P < 0.05) (Fig. 3). The results showed that Ca2+-inde-
pendent PC-PLC was likely implicated in safrole oxide
triggered VEC apoptosis.
3.4. Eﬀect of safrole oxide on the expression of integrin b4
As shown in Fig. 4, the expression of integrin b4 in control
group is very low, but in the experimental group treated with
safrole oxide, the expression of this protein was obviously in-
creased (P< 0.01). Moreover, the subcellular distribution of
integrin b4 in the cells treated by safrole oxide was changed,
not only it was in the cell membrane, but also in the nucleus.
But, in the cells of control group, integrin b4 diﬀusely distrib-
uted at the cell surface (Fig. 4A). The results showed that inte-
grin b4 was translocated from membrane and cytoplasm to
nucleus, and it might act as an important signal molecule in
VEC apoptosis induced by safrole oxide.
3.5. Eﬀect of safrole oxide on the expression of P53
The expression of P53 was examined by immunoﬂuorescence
assay. The levels of P53 protein in cells treated with safrole
oxide were higher than that of the control (P < 0.05)
(Fig. 5). The results showed that P53 was likely involved in
the apoptotic signal transduction induced by safrole oxide.
3.6. Eﬀect of safrole oxide on the level of ROS
As shown in Fig. 6, in the cells of control group, the relative
ﬂuorescent intensity of DCF was very high, but when the cellsf proteins from Western blot assay. (B) The relative quantity of Fas,
hs show the relative intensity and the location of Fas in VEC. (a) Cells
) The quantity of expressed Fas. The value in the ﬁgures represents the
icroscopy 10 h after the start of treatment. **, P < 0.01 vs. #, n = 3.
Fig. 2. Eﬀect of safrole oxide on NOS activity. Cells were treated with
or without safrole oxide for 10 h, then the enzyme activity was
analyzed. &, P > 0.05 vs. #, n = 3.
Fig. 3. Eﬀect of safrole oxide on PC-PLC activity. The activity of PC-
PLC, including Ca2+-dependent PC-PLC and Ca2+-independent PC-
PLC, was evaluated following treatment with 70 mg/L of safrole oxide
for 10 h. &, P > 0.05 vs. #1; *, P < 0.05 vs. #2, n = 3.
Fig. 4. Eﬀect of safrole oxide on the level of integrin b4 and the location of th
the location of integrin b4 in VEC. (a) Cells cultured in the basal medium; (b)
integrin b4. The value in the ﬁgures represents the relative ﬂuorescent intensi
the start of treatment. **, P < 0.01 vs. #, n = 3.
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sity decreased signiﬁcantly (Fig. 6A, P < 0.05). Our results
showed that safrole oxide could depress intracellular ROS lev-
els, which indicated that ROS might be important elements in
the apoptosis signal pathway induced by safrole oxide.4. Discussion
The regulation of endothelial cell apoptosis was as a poten-
tial therapeutic target to blood vessel disease. Previously, we
found that safrole oxide was a VEC apoptosis promoter. In
this study, our data further showed that safrole oxide induced
VEC apoptosis by upregulating Fas, integrin b4, P53 and
depressing PC-PLC activity and ROS level.
Apoptosis of VEC is likely regulated by survival and death
signals. Among the survival signals, NOS is an important ele-
ment [14]. Activation of the endothelial NOS, leads to en-
hanced synthesis of NO, which promotes endothelial cell
survival. Inhibition of the survival signaling pathways medi-
ated by NO caused massive endothelial cell apoptosis [15].
However, our data in this study suggested that NOS was not
involved in VEC apoptosis induced by safrole oxide.
Fas (APO-1 or CD95) functions to transmit death signal in
many kinds of cells. But, activation of the classical apoptotic
APO-1/Fas pathway in VEC is discussed controversially
[16,17]. In this study, we found that when safrole oxide trig-
gered VEC apoptosis, it could elevate the expression of Fas
obviously. The data indicated that safrole oxide might be an
eﬀective promoter of Fas mediated signal pathway.
PC-PLC is implicated in several models of programmed cell
death including VEC apoptosis [9,18]. And PC-PLC is a neces-
sary intermediate in transducing apoptotic signals for Fas/
Apo-1 ligands in nonneuronal cells [19]. To know the action
of PC-PLC in VEC apoptosis induced by safrole oxide and
the relationship between PC-PLC and Fas in endothelial cell
apoptosis, the activity of PC-PLC was examined. Our ﬁndings
in this study demonstrated that Ca2+-independent PC-PLC
participated in the safrole oxide induced VEC apoptosis. Our
data ﬁrst suggested that PC-PLC might be an important ele-
ment in Fas mediated apoptosis signal pathway of VEC.
Our previous experiment results showed that integrin b4
expression and distribution in VEC associated with the activityis protein. (A) Fluorescent micrographs show the relative intensity and
cells treated with safrole oxide 70 mg/L. (B) The quantity of expressed
ty per cell determined by laser scanning confocal microscopy 10 h after
Fig. 5. Eﬀect of safrole oxide on the expression of P53. (A) Fluorescent micrographs show the location and the relative intensity of P53. (a) Cells
cultured in the basal medium; (b) cells treated with safrole oxide 70 mg/L, respectively. (B) The quantity of expressed P53. *, P < 0.05 vs. #, n = 3.
Fig. 6. Eﬀect of safrole oxide on ROS level. (A) Fluorescent micrographs show the relative intensity of DCHF in VEC. (a) Cells cultured in the basal
medium; (b) cells treated with safrole oxide 70 mg/L, respectively. (B) The quantity of DCHF. **, P < 0.01 vs. #, n = 3.
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cellular signal transduction, and involved in endothelial cell
death induced by deprived of ﬁbroblast growth factor (FGF)
[21,22]. The endothelial expression of integrin b4 is negatively
regulated during angiogenesis [23]. In this study, the expression
of this protein in the cells treated with 70 mg/L of safrole oxide
was obviously up-regulated (P < 0.01), at the same time, it was
translocated from membrane and cytoplasm to nucleus. The
data suggested that it might be an important protein in VEC
apoptosis induced by safrole oxide.
P53 is another key protein in VEC associated with the activ-
ity of PC-PLC and plays an important role in VEC apoptosis
[9,20]. The results in the present study showed that P53 protein
might participate in safrole oxide induced apoptosis, although
the relations of PC-PLC, integrin b4 and P53 are not clear.
Accumulated evidence has demonstrated that ROS act as
important signals in apoptosis. However, previous reports
showed that apoptosis occurred when intracellular ROS was
elevated [24]. In this study, the level of ROS in cells treated
by safrole oxide was decreased signiﬁcantly. Taken altogether,
the balance of intracellular ROS might be very important to
cell survival. Very low level of ROS might have a proapoptotic
eﬀect as very high level of ROS.
In summary, our results in this study showed that safrole
oxide induced VEC apoptosis by up-regulating the expressions
of Fas, integrin b4 and P53 and reducing the activity of PC-
PLC and ROS. That provided new clues to explore its targetin a chemical genetics perspective. Cell-permeable safrole oxide
can be used as a chemical probe for understanding the func-
tions of target proteins. It could be an exciting tool to advance
functional researches of genes and proteins in VEC apoptosis
and vascular disease.
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